Symbol:
Kdm5b
Name:
lysine demethylase 5B
RGD ID:
1565602
Description:
Predicted to enable several functions, including histone H3K4me/H3K4me2/H3K4me3 demethylase activity; transcription corepressor activity; and zinc ion binding activity. Involved in cellular response to fibroblast growth factor stimulus; lens fiber cell differentiation; and response to fungicide. Predicted to be located in cytosol and nucleoplasm. Predicted to be active in chromatin and nucleus. Human ortholog(s) of this gene implicated in autosomal recessive intellectual developmental disorder 65; breast cancer; and high grade glioma. Orthologous to human KDM5B (lysine demethylase 5B); PARTICIPATES IN histone modification pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; amitrole.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Jarid1b; jumonji, AT rich interactive domain 1B; jumonji, AT rich interactive domain 1B (Rbp2 like); Jumonji, AT rich interactive domain 1B (RBP2-like); LOC304809; lysine (K)-specific demethylase 5B; lysine-specific demethylase 5B; RGD1565602; similar to PLU1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
KDM5B (lysine demethylase 5B)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, Panther
Mus musculus (house mouse):
Kdm5b (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Kdm5b (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
KDM5B (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
KDM5B (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Kdm5b (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
KDM5B (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
KDM5B (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Kdm5b (lysine demethylase 5B)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
KDM5B (lysine demethylase 5B)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Kdm5b (lysine demethylase 5B)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
kdm5bb (lysine (K)-specific demethylase 5Bb)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
kdm5ba (lysine (K)-specific demethylase 5Ba)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
lid
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
rbr-2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
JHD2
Alliance
DIOPT (Ensembl Compara|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
kdm5b
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 48,554,367 - 48,625,721 (+) NCBI GRCr8 mRatBN7.2 13 46,001,589 - 46,073,868 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 46,002,542 - 46,073,872 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 48,608,619 - 48,679,295 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 49,896,685 - 49,967,365 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 47,162,325 - 47,233,666 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 51,384,371 - 51,455,392 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 51,384,389 - 51,455,357 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 56,438,019 - 56,509,593 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 47,502,602 - 47,576,946 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 13 46,328,788 - 46,400,255 (+) NCBI Celera Cytogenetic Map 13 q13 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Kdm5b Rat 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene multiple interactions ISO RGD:1557118 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kdm5b Rat 1,2-dichloroethane increases expression ISO RGD:1557118 6480464 ethylene dichloride results in increased expression of KDM5B mRNA CTD PMID:28960355 Kdm5b Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1557118 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KDM5B mRNA CTD PMID:22206623 Kdm5b Rat 17alpha-ethynylestradiol affects expression ISO RGD:1557118 6480464 Ethinyl Estradiol affects the expression of KDM5B mRNA CTD PMID:17555576 Kdm5b Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1557118 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kdm5b Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1557118 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kdm5b Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KDM5B mRNA CTD PMID:34747641 Kdm5b Rat 2,4,4'-trichlorobiphenyl multiple interactions ISO RGD:1557118 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kdm5b Rat 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1557118 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KDM5B mRNA CTD PMID:20188158 Kdm5b Rat 4,4'-diaminodiphenylmethane increases expression ISO RGD:1557118 6480464 4,4'-diaminodiphenylmethane results in increased expression of KDM5B mRNA CTD PMID:18648102 Kdm5b Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KDM5B mRNA CTD PMID:30047161 Kdm5b Rat acetylsalicylic acid decreases expression ISO RGD:1322449 6480464 Aspirin results in decreased expression of KDM5B mRNA CTD PMID:15928584 Kdm5b Rat all-trans-retinoic acid decreases expression ISO RGD:1557118 6480464 Tretinoin results in decreased expression of KDM5B mRNA CTD PMID:16788091 Kdm5b Rat all-trans-retinoic acid increases expression ISO RGD:1322449 6480464 Tretinoin results in increased expression of KDM5B mRNA CTD PMID:22906706|PMID:23724009 Kdm5b Rat all-trans-retinoic acid decreases expression ISO RGD:1322449 6480464 Tretinoin results in decreased expression of KDM5B mRNA CTD PMID:15498508 Kdm5b Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of KDM5B mRNA CTD PMID:30047161|PMID:38685447 Kdm5b Rat antimycin A decreases expression ISO RGD:1322449 6480464 Antimycin A results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat atrazine increases expression ISO RGD:1557118 6480464 Atrazine results in increased expression of KDM5B mRNA CTD PMID:27655631 Kdm5b Rat benzene increases expression ISO RGD:1322449 6480464 Benzene results in increased expression of KDM5B mRNA CTD PMID:19162166 Kdm5b Rat benzo[a]pyrene increases expression ISO RGD:1557118 6480464 Benzo(a)pyrene results in increased expression of KDM5B mRNA CTD PMID:20504355 Kdm5b Rat benzo[a]pyrene affects methylation ISO RGD:1322449 6480464 Benzo(a)pyrene affects the methylation of KDM5B promoter CTD PMID:27901495 Kdm5b Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1322449 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KDM5B mRNA CTD PMID:19150397|PMID:20018196 Kdm5b Rat benzo[b]fluoranthene decreases expression ISO RGD:1557118 6480464 benzo(b)fluoranthene results in decreased expression of KDM5B mRNA CTD PMID:26377693 Kdm5b Rat berberine increases expression ISO RGD:1322449 6480464 Berberine results in increased expression of KDM5B mRNA CTD PMID:27311644 Kdm5b Rat beta-lapachone increases expression ISO RGD:1322449 6480464 beta-lapachone results in increased expression of KDM5B mRNA CTD PMID:38218311 Kdm5b Rat bis(2-chloroethyl) sulfide decreases expression ISO RGD:1557118 6480464 Mustard Gas results in decreased expression of KDM5B mRNA CTD PMID:26392148 Kdm5b Rat bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1557118 6480464 Diethylhexyl Phthalate results in decreased expression of KDM5B mRNA CTD PMID:33754040 Kdm5b Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KDM5B mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 Kdm5b Rat bisphenol A decreases expression ISO RGD:1322449 6480464 bisphenol A results in decreased expression of KDM5B mRNA CTD PMID:31610501 Kdm5b Rat bisphenol A multiple interactions ISO RGD:1322449 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KDM5B gene CTD PMID:31601247 Kdm5b Rat bisphenol A increases expression ISO RGD:1557118 6480464 bisphenol A results in increased expression of KDM5B mRNA CTD PMID:30303745 Kdm5b Rat bisphenol A increases expression ISO RGD:1322449 6480464 bisphenol A results in increased expression of KDM5B mRNA CTD PMID:29275510 Kdm5b Rat bisphenol A affects methylation ISO RGD:1557118 6480464 bisphenol A affects the methylation of KDM5B promoter CTD PMID:27334623 Kdm5b Rat cadmium atom decreases expression ISO RGD:1322449 6480464 Cadmium results in decreased expression of KDM5B mRNA CTD PMID:23369406 Kdm5b Rat cadmium dichloride decreases expression ISO RGD:1322449 6480464 Cadmium Chloride results in decreased expression of KDM5B mRNA CTD PMID:38568856 Kdm5b Rat carbamazepine affects expression ISO RGD:1322449 6480464 Carbamazepine affects the expression of KDM5B mRNA CTD PMID:25979313 Kdm5b Rat carbon nanotube decreases expression ISO RGD:1557118 6480464 Nanotubes, Carbon analog results in decreased expression of KDM5B mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 Kdm5b Rat CGP 52608 multiple interactions ISO RGD:1322449 6480464 CGP 52608 promotes the reaction [RORA protein binds to KDM5B gene] CTD PMID:28238834 Kdm5b Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of KDM5B mRNA CTD PMID:18668222 Kdm5b Rat cisplatin decreases expression ISO RGD:1322449 6480464 Cisplatin results in decreased expression of KDM5B mRNA CTD PMID:27594783 Kdm5b Rat cobalt dichloride increases expression ISO RGD:1322449 6480464 cobaltous chloride results in increased expression of KDM5B mRNA CTD PMID:19376846 Kdm5b Rat copper(II) sulfate increases expression ISO RGD:1322449 6480464 Copper Sulfate results in increased expression of KDM5B mRNA CTD PMID:19549813 Kdm5b Rat coumestrol multiple interactions ISO RGD:1322449 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA; [Coumestrol co-treated with resveratrol] more ... CTD PMID:19167446 Kdm5b Rat coumestrol decreases expression ISO RGD:1322449 6480464 Coumestrol results in decreased expression of KDM5B mRNA CTD PMID:19167446 Kdm5b Rat crocidolite asbestos increases expression ISO RGD:1322449 6480464 Asbestos, Crocidolite results in increased expression of KDM5B mRNA CTD PMID:18687144 Kdm5b Rat crocidolite asbestos decreases expression ISO RGD:1557118 6480464 Asbestos, Crocidolite results in decreased expression of KDM5B mRNA CTD PMID:29279043 Kdm5b Rat cyclosporin A decreases expression ISO RGD:1322449 6480464 Cyclosporine results in decreased expression of KDM5B mRNA CTD PMID:27989131 Kdm5b Rat deguelin decreases expression ISO RGD:1322449 6480464 deguelin results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat Dibutyl phosphate affects expression ISO RGD:1322449 6480464 di-n-butylphosphoric acid affects the expression of KDM5B mRNA CTD PMID:37042841 Kdm5b Rat dioxygen multiple interactions ISO RGD:1322449 6480464 KDM5B protein promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA] CTD PMID:25043185 Kdm5b Rat dioxygen decreases expression ISO RGD:1322449 6480464 Oxygen deficiency results in decreased expression of KDM5B protein CTD PMID:25043185 Kdm5b Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of KDM5B mRNA CTD PMID:25152437 Kdm5b Rat doxorubicin increases expression ISO RGD:1322449 6480464 Doxorubicin results in increased expression of KDM5B mRNA CTD PMID:29803840 Kdm5b Rat Enterolactone multiple interactions ISO RGD:1322449 6480464 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA CTD PMID:19167446 Kdm5b Rat ethanol decreases expression ISO RGD:1322449 6480464 Ethanol results in decreased expression of KDM5B protein CTD PMID:35149083 Kdm5b Rat fenpyroximate decreases expression ISO RGD:1322449 6480464 fenpyroximate results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat folic acid multiple interactions ISO RGD:1557118 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KDM5B mRNA CTD PMID:22206623 Kdm5b Rat FR900359 affects phosphorylation ISO RGD:1322449 6480464 FR900359 affects the phosphorylation of KDM5B protein CTD PMID:37730182 Kdm5b Rat fulvestrant multiple interactions ISO RGD:1322449 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KDM5B gene CTD PMID:31601247 Kdm5b Rat fumonisin B1 increases expression ISO RGD:1322449 6480464 fumonisin B1 results in increased expression of KDM5B mRNA CTD PMID:24280379 Kdm5b Rat hydrogen chloride decreases expression ISO RGD:1322449 6480464 Hydrochloric Acid results in decreased expression of KDM5B mRNA CTD PMID:15046208 Kdm5b Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of KDM5B mRNA CTD PMID:30047161 Kdm5b Rat nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of KDM5B mRNA CTD PMID:24136188 Kdm5b Rat niclosamide increases expression ISO RGD:1322449 6480464 Niclosamide results in increased expression of KDM5B mRNA CTD PMID:36318118 Kdm5b Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KDM5B mRNA CTD PMID:25729387 Kdm5b Rat parathion decreases expression ISO RGD:1557118 6480464 Parathion results in decreased expression of KDM5B mRNA CTD PMID:34813904 Kdm5b Rat PCB138 multiple interactions ISO RGD:1557118 6480464 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... CTD PMID:25510870 Kdm5b Rat phenobarbital affects expression ISO RGD:1557118 6480464 Phenobarbital affects the expression of KDM5B mRNA CTD PMID:23091169 Kdm5b Rat picoxystrobin decreases expression ISO RGD:1322449 6480464 picoxystrobin results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat pyrimidifen decreases expression ISO RGD:1322449 6480464 pyrimidifen results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat resveratrol multiple interactions ISO RGD:1322449 6480464 [Coumestrol co-treated with Resveratrol] results in decreased expression of KDM5B mRNA; [Plant Extracts co-treated with more ... CTD PMID:19167446|PMID:23557933 Kdm5b Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of KDM5B mRNA CTD PMID:19013527 Kdm5b Rat rotenone decreases expression ISO RGD:1322449 6480464 Rotenone results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat sodium arsenate decreases expression ISO RGD:1557118 6480464 sodium arsenate results in decreased expression of KDM5B protein CTD PMID:26193056 Kdm5b Rat sodium arsenate increases expression ISO RGD:1557118 6480464 sodium arsenate results in increased expression of KDM5B mRNA CTD PMID:21795629 Kdm5b Rat sodium arsenite increases expression ISO RGD:1322449 6480464 sodium arsenite results in increased expression of KDM5B mRNA CTD PMID:38568856 Kdm5b Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of KDM5B mRNA CTD PMID:30047161 Kdm5b Rat tamibarotene affects expression ISO RGD:1322449 6480464 tamibarotene affects the expression of KDM5B mRNA CTD PMID:15498508 Kdm5b Rat tamoxifen affects expression ISO RGD:1557118 6480464 Tamoxifen affects the expression of KDM5B mRNA CTD PMID:17555576 Kdm5b Rat tebufenpyrad decreases expression ISO RGD:1322449 6480464 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of KDM5B mRNA CTD PMID:33512557 Kdm5b Rat titanium dioxide decreases methylation ISO RGD:1557118 6480464 titanium dioxide results in decreased methylation of KDM5B promoter alternative form CTD PMID:35295148 Kdm5b Rat titanium dioxide decreases expression ISO RGD:1557118 6480464 titanium dioxide results in decreased expression of KDM5B mRNA CTD PMID:35295148 Kdm5b Rat titanium dioxide increases methylation ISO RGD:1557118 6480464 titanium dioxide results in increased methylation of KDM5B gene CTD PMID:35295148 Kdm5b Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KDM5B mRNA CTD PMID:25729387 Kdm5b Rat triphenyl phosphate affects expression ISO RGD:1322449 6480464 triphenyl phosphate affects the expression of KDM5B mRNA CTD PMID:37042841 Kdm5b Rat triptonide increases expression ISO RGD:1557118 6480464 triptonide results in increased expression of KDM5B mRNA CTD PMID:33045310 Kdm5b Rat troglitazone increases expression ISO RGD:1322449 6480464 troglitazone results in increased expression of KDM5B mRNA CTD PMID:19140230 Kdm5b Rat tungsten decreases expression ISO RGD:1557118 6480464 Tungsten results in decreased expression of KDM5B mRNA CTD PMID:30912803 Kdm5b Rat uranium atom affects expression ISO RGD:1322449 6480464 Uranium affects the expression of KDM5B mRNA CTD PMID:15672453 Kdm5b Rat urethane increases expression ISO RGD:1322449 6480464 Urethane results in increased expression of KDM5B mRNA CTD PMID:28818685 Kdm5b Rat valproic acid decreases expression ISO RGD:1322449 6480464 Valproic Acid results in decreased expression of KDM5B mRNA CTD PMID:23179753 Kdm5b Rat valproic acid affects expression ISO RGD:1322449 6480464 Valproic Acid affects the expression of KDM5B mRNA CTD PMID:25979313 Kdm5b Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KDM5B mRNA CTD PMID:19015723
1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP) 2,4,4'-trichlorobiphenyl (ISO) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-diaminodiphenylmethane (ISO) 6-propyl-2-thiouracil (EXP) acetylsalicylic acid (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) antimycin A (ISO) atrazine (ISO) benzene (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[b]fluoranthene (ISO) berberine (ISO) beta-lapachone (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) cadmium dichloride (ISO) carbamazepine (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chlorpyrifos (EXP) cisplatin (ISO) cobalt dichloride (ISO) copper(II) sulfate (ISO) coumestrol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) deguelin (ISO) Dibutyl phosphate (ISO) dioxygen (ISO) diuron (EXP) doxorubicin (ISO) Enterolactone (ISO) ethanol (ISO) fenpyroximate (ISO) folic acid (ISO) FR900359 (ISO) fulvestrant (ISO) fumonisin B1 (ISO) hydrogen chloride (ISO) methimazole (EXP) nefazodone (EXP) niclosamide (ISO) oxaliplatin (EXP) parathion (ISO) PCB138 (ISO) phenobarbital (ISO) picoxystrobin (ISO) pyrimidifen (ISO) resveratrol (ISO) rotenone (EXP,ISO) sodium arsenate (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) tamibarotene (ISO) tamoxifen (ISO) tebufenpyrad (ISO) titanium dioxide (ISO) topotecan (EXP) triphenyl phosphate (ISO) triptonide (ISO) troglitazone (ISO) tungsten (ISO) uranium atom (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP)
Biological Process
branching involved in mammary gland duct morphogenesis (IEA,ISO) cellular response to fibroblast growth factor stimulus (IEP) cellular response to leukemia inhibitory factor (IEA,ISO) chromatin organization (IEA) chromatin remodeling (IBA) lens fiber cell differentiation (IEP) mammary duct terminal end bud growth (IEA,ISO) negative regulation of DNA-templated transcription (IEA,ISO) positive regulation of gene expression (IEA,ISO) positive regulation of mammary gland epithelial cell proliferation (IEA,ISO) post-embryonic development (IEA,ISO) regulation of DNA-templated transcription (IBA) regulation of estradiol secretion (IEA,ISO) response to fungicide (IEP) single fertilization (IEA,ISO) uterus morphogenesis (IEA,ISO)
1.
Coexpression of nuclear receptors and histone methylation modifying genes in the testis: implications for endocrine disruptor modes of action.
Anderson AM, etal., PLoS One. 2012;7(4):e34158. doi: 10.1371/journal.pone.0034158. Epub 2012 Apr 4.
2.
Histone lysine methylation dynamics: establishment, regulation, and biological impact.
Black JC, etal., Mol Cell. 2012 Nov 30;48(4):491-507. doi: 10.1016/j.molcel.2012.11.006.
3.
PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.
Catchpole S, etal., Int J Oncol. 2011 May;38(5):1267-77. doi: 10.3892/ijo.2011.956. Epub 2011 Feb 28.
4.
Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
Dai B, etal., Biochem Biophys Res Commun. 2014 Nov 7;454(1):221-7. doi: 10.1016/j.bbrc.2014.10.078. Epub 2014 Oct 22.
5.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6.
Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
Hayami S, etal., Mol Cancer. 2010 Mar 13;9:59. doi: 10.1186/1476-4598-9-59.
7.
Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).
Li Y, etal., Cardiovasc Pathol. 2018 Nov-Dec;37:8-14. doi: 10.1016/j.carpath.2018.07.004. Epub 2018 Aug 3.
8.
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer.
Lu PJ, etal., J Biol Chem. 1999 May 28;274(22):15633-45.
9.
Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K, etal., Int J Oncol. 2013 Apr;42(4):1212-8. doi: 10.3892/ijo.2013.1799. Epub 2013 Jan 25.
10.
JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P, etal., Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4442-9. doi: 10.1167/iovs.11-9296.
11.
GOA pipeline
RGD automated data pipeline
12.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
13.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
14.
Comprehensive gene review and curation
RGD comprehensive gene curation
15.
Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
Sun LL, etal., Acta Histochem. 2013 Jan;115(1):56-62. doi: 10.1016/j.acthis.2012.04.001. Epub 2012 Apr 23.
16.
Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression.
Wang B, etal., Exp Mol Med. 2022 Dec;54(12):2175-2187. doi: 10.1038/s12276-022-00904-y. Epub 2022 Dec 8.
17.
Identification and characterization of FGF2-dependent mRNA: microRNA networks during lens fiber cell differentiation.
Wolf L, etal., G3 (Bethesda). 2013 Dec 9;3(12):2239-55. doi: 10.1534/g3.113.008698.
18.
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
Xiang Y, etal., Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19226-31. Epub 2007 Nov 28.
Kdm5b (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 48,554,367 - 48,625,721 (+) NCBI GRCr8 mRatBN7.2 13 46,001,589 - 46,073,868 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 46,002,542 - 46,073,872 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 48,608,619 - 48,679,295 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 49,896,685 - 49,967,365 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 47,162,325 - 47,233,666 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 51,384,371 - 51,455,392 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 51,384,389 - 51,455,357 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 56,438,019 - 56,509,593 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 47,502,602 - 47,576,946 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 13 46,328,788 - 46,400,255 (+) NCBI Celera Cytogenetic Map 13 q13 NCBI
KDM5B (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 202,724,495 - 202,808,421 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 202,724,495 - 202,808,487 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 202,693,623 - 202,777,549 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 200,963,155 - 201,044,172 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 199,428,188 - 199,509,206 NCBI Celera 1 175,824,418 - 175,906,769 (-) NCBI Celera Cytogenetic Map 1 q32.1 NCBI HuRef 1 173,862,355 - 173,943,136 (-) NCBI HuRef CHM1_1 1 204,118,752 - 204,199,788 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 201,986,695 - 202,071,080 (-) NCBI T2T-CHM13v2.0
Kdm5b (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 1 134,487,916 - 134,560,621 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 1 134,487,909 - 134,563,023 (+) Ensembl GRCm39 Ensembl GRCm38 1 134,560,178 - 134,632,878 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 1 134,560,171 - 134,635,285 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 1 136,456,755 - 136,529,455 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 1 136,376,606 - 136,449,288 (+) NCBI MGSCv36 mm8 Celera 1 137,167,324 - 137,243,758 (+) NCBI Celera Cytogenetic Map 1 E4 NCBI cM Map 1 58.24 NCBI
Kdm5b (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955406 38,755,220 - 38,823,088 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955406 38,755,220 - 38,823,094 (-) NCBI ChiLan1.0 ChiLan1.0
KDM5B (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 46,574,059 - 46,654,480 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 46,540,718 - 46,623,372 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 178,323,073 - 178,406,608 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 182,620,358 - 182,702,994 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 182,622,425 - 182,702,994 (-) Ensembl panpan1.1 panPan2
KDM5B (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 336,452 - 415,568 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 330,705 - 412,386 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 389,052 - 475,184 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 343,885 - 430,080 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 339,836 - 422,462 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 332,707 - 418,792 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 441,516 - 527,633 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 464,790 - 550,918 (+) NCBI UU_Cfam_GSD_1.0
Kdm5b (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 72,547,343 - 72,626,164 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936567 1,781,995 - 1,863,461 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936567 1,782,056 - 1,860,861 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
KDM5B (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 10 24,736,838 - 24,831,447 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 10 24,739,115 - 24,831,537 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 10 29,186,615 - 29,191,730 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
KDM5B (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 25 26,599,740 - 26,685,256 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 25 26,600,736 - 26,683,632 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666055 27,379,047 - 27,463,383 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Kdm5b (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 179 Count of miRNA genes: 125 Interacting mature miRNAs: 151 Transcripts: ENSRNOT00000006290 Prediction methods: Miranda, Targetscan Result types: miRGate_prediction
10755495 Bp387 Blood pressure QTL 387 3.78 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34663461 87525369 Rat 9589141 Insul28 Insulin level QTL 28 10.82 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 13 9313465 54313465 Rat 6893344 Cm79 Cardiac mass QTL 79 1.5 0.04 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 43720770 62022792 Rat 70220 Bp55 Blood pressure QTL 55 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 61391 Bp5 Blood pressure QTL 5 5.6 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 22301875 67301875 Rat 4889861 Pur29 Proteinuria QTL 29 13.8 0.005 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 13 37415584 80753406 Rat 2317040 Aia21 Adjuvant induced arthritis QTL 21 2.75 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 631645 Bp121 Blood pressure QTL 121 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 14915655 59915655 Rat 2317046 Aia8 Adjuvant induced arthritis QTL 8 3.9700000286102295 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 13 9831541 54831541 Rat 12879441 Bp396 Blood pressure QTL 396 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 45699983 90699983 Rat 619615 Bp80 Blood pressure QTL 80 0.0354 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 39754544 84754544 Rat 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 8897350 101631289 Rat 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 0.0024 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 23203448 68203448 Rat 1331784 Bp222 Blood pressure QTL 222 2.944 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 17694436 53050594 Rat 61340 Bp25 Blood pressure QTL 25 4.2 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34535218 79535218 Rat 1581573 Uae36 Urinary albumin excretion QTL 36 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 1549897 Stresp12 Stress response QTL 12 3.35 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 13 38433408 83433408 Rat 2302275 Gluco37 Glucose level QTL 37 3.8 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 13 11929449 46193066 Rat 7207885 Glom27 Glomerulus QTL 27 3.9 kidney glomerulus integrity trait (VT:0010546) kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139) 13 20605871 101339738 Rat 4145117 Mcs27 Mammary carcinoma susceptibility QTL 27 0.0001 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 13 43437904 47841255 Rat 1558644 Cm45 Cardiac mass QTL 45 3.6 0.002 heart mass (VT:0007028) heart wet weight (CMO:0000069) 13 23692969 68692969 Rat 70181 BpQTLcluster11 Blood pressure QTL cluster 11 6.922 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 13 31241331 93395974 Rat 61349 Bp31 Blood pressure QTL 31 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 2303563 Bw89 Body weight QTL 89 6 body mass (VT:0001259) body weight (CMO:0000012) 13 32284471 77284471 Rat 1354621 Rf47 Renal function QTL 47 3.7 kidney renin amount (VT:0010559) kidney renin level (CMO:0002166) 13 30395351 101056920 Rat 2301962 Cm72 Cardiac mass QTL 72 4.12 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 13 31241331 58363171 Rat 1581554 Pur11 Proteinuria QTL 11 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 12879477 Bp401 Blood pressure QTL 401 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 37262092 82262092 Rat 1331750 Bp220 Blood pressure QTL 220 2.98 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 37415584 82415584 Rat 6893338 Cm76 Cardiac mass QTL 76 0 0.99 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 23692969 68692969 Rat 12879472 Bp399 Blood pressure QTL 399 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 45228358 47841255 Rat 1354666 Bp244 Blood pressure QTL 244 4.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 1 101056920 Rat 9589164 Gluco66 Glucose level QTL 66 6.67 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 13 15158722 60158722 Rat 7411662 Foco29 Food consumption QTL 29 20.8 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 13 9313465 54313465 Rat
D13Mco9
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 46,025,527 - 46,025,790 (+) MAPPER mRatBN7.2 Rnor_6.0 13 51,407,374 - 51,407,636 NCBI Rnor6.0 Rnor_5.0 13 56,461,941 - 56,462,203 UniSTS Rnor5.0 RGSC_v3.4 13 47,525,586 - 47,525,849 RGD RGSC3.4 RGSC_v3.4 13 47,525,587 - 47,525,849 UniSTS RGSC3.4 RGSC_v3.1 13 47,539,629 - 47,539,892 RGD Celera 13 46,351,767 - 46,352,029 UniSTS Cytogenetic Map 13 q13 UniSTS
RH132812
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 13 46,073,515 - 46,073,720 (+) MAPPER mRatBN7.2 Rnor_6.0 13 51,455,032 - 51,455,236 NCBI Rnor6.0 Rnor_5.0 13 56,509,241 - 56,509,445 UniSTS Rnor5.0 RGSC_v3.4 13 47,576,594 - 47,576,798 UniSTS RGSC3.4 Celera 13 46,399,903 - 46,400,107 UniSTS RH 3.4 Map 13 171.0 UniSTS Cytogenetic Map 13 q13 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000077928 ⟹ ENSRNOP00000073808
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 46,002,542 - 46,073,872 (+) Ensembl Rnor_6.0 Ensembl 13 51,384,562 - 51,453,906 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000087025 ⟹ ENSRNOP00000072712
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 46,002,542 - 46,073,868 (+) Ensembl Rnor_6.0 Ensembl 13 51,384,389 - 51,455,357 (+) Ensembl
RefSeq Acc Id:
NM_001107177 ⟹ NP_001100647
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,554,397 - 48,625,713 (+) NCBI mRatBN7.2 13 46,002,542 - 46,073,868 (+) NCBI Rnor_6.0 13 51,384,396 - 51,455,384 (+) NCBI Rnor_5.0 13 56,438,019 - 56,509,593 (+) NCBI RGSC_v3.4 13 47,502,602 - 47,576,946 (+) RGD Celera 13 46,328,788 - 46,400,255 (+) RGD
Sequence:
CAAGACGTCGTCGGAGGAAGGCTGAAAAAGCCCTAGGTGTTGCCGTTGCTAGTAGAAGTCGGACTTGTCGCCCGAGCTGTGCGTGTGCACAGGTTTCGGACGGAGCGGAGCTCGCTGCCGCGGTTGCG GAGCTTGCCCTGTGCTCGCCCCTGCCCACGTCGCGGTGATGGAGCCGGCCACCGCGCTGCCCCCAGGCCCGCGCCCGGCGCTGCCCCTTGGGGGCCCCGGCCCGCTGGGAGAGTTCCTGCCTCCCCCC GAGTGTCCGGTCTTCGAGCCCAGCTGGGAAGAGTTCGCGGACCCCTTCGCTTTCATCCACAAGATCCGGCCCATAGCCGAGCAGACTGGGATCTGTAAGGTGCGGCCGCCGCCGGATTGGCAGCCACC ATTCGCTTGTGATGTTGATAAACTTCATTTTACCCCGCGTATCCAGAGGCTTAATGAGCTGGAGGCCCAAACACGTGTAAAATTGAACTTCCTGGACCAGATTGCCAAGTATTGGGAGCTACAGGGAA GTACTCTGAAGATTCCTCATGTGGAGAGAAAGATCTTAGACTTGTTCCAGCTAAATAAGTTAGTTGCAGAGGAAGGTGGGTTTGCAGTTGTTTGCAAGGACAGAAAATGGACCAAAATTGCCACCAAG ATGGGTTTTGCTCCTGGTAAAGCAGTGGGCTCACATATCAGGGGACATTATGAGCGAATCCTCAATCCGTACAATTTGTTCCTATCTGGGGACAGCCTGAGGTGTCTTCAGAAGCCTAACCTGACCTC GGACACAAAGGACAAGGAGTACAAACCCCATGATATTCCCCAGAGGCAGTCTGTGCAGCCCTCAGAAACCTGCCCTCCGGCCCGCCGAGCAAAGCGCATGAGAGCAGAGGCTATGAATATTAAAATTG AGCCAGAAGAGGCAACAGAAGCCAGGACTCATAACCTGAGGCGCCGAATGGGCTGTGCCACTCCAAAACGGGAAAACGAGAAAGAAGTGAAAAGTACCATCAAGCAAGAACCCACCGAGAAGAAAGAC TGTGTGTTAGAAAGTGAGAAGGACAAGCCCAAGAGCCGTGCCAAGAAAACCGCCACTGCTGTGGACCTGTATGTGTGCCTCTTATGTGGCAGCGGCAATGACGAGGACCGGCTGCTCCTGTGTGACGG CTGTGACGACAGTTACCACACCTTCTGCCTGCTTCCCCCTCTCCATGATGTTCCCAAGGGAGACTGGAGGTGTCCTAAGTGTTTGGCTCAAGAGTGTAGTAAGCCACAAGAAGCTTTCGGCTTTGAAC AGGCTGCAAGGGACTATACACTCCGTACGTTTGGGGAAATGGCAGATGCATTCAAATCTGATTACTTCAACATGCCGGTCCATATGGTTCCCACAGAGCTGGTGGAGAAGGAGTTTTGGCGGCTGGTA AGCACTATTGAAGAAGACGTCACCGTGGAGTATGGAGCTGATATTGCTTCAAAAGAGTTTGGCAGTGGCTTTCCTGTTCGAGATGGCAAAATCAAGATTTCTCCTGAGGAAGAGGAGTATCTTGATAG TGGCTGGAATTTGAATAACATGCCAGTGATGGAGCAGTCTGTCCTTGCTCACATTACTGCTGATATATGCGGCATGAAACTGCCTTGGTTGTATGTGGGCATGTGCTTTTCTTCCTTCTGTTGGCATA TCGAAGACCACTGGAGCTATTCAATCAACTACCTGCACTGGGGTGAGCCGAAAACCTGGTATGGAGTTCCAGGATATGCTGCTGAGCAGCTTGAAAACGTAATGAAGAAGCTGGCTCCAGAGCTCTTT GTGTCCCAGCCAGACCTCCTCCACCAGCTTGTGACGATCATGAACCCCAATACGCTGATGACTCACGAAGTGCCTGTGTATCGAACGAATCAGTGTGCTGGGGAGTTTGTCATTACGTTCCCGAGAGC CTACCACAGTGGCTTCAATCAAGGCTTTAATTTTGCTGAGGCAGTTAACTTCTGCACTGTTGATTGGCTGCCGTTGGGCCGCCAGTGCGTGGAGCATTATCGCCTGCTGCACCGCTACTGCGTCTTTT CCCATGATGAGATGATATGCAAGATGGCTTCCAAGGCTGATGTGTTAGACGTGGTAGTGGCATCCACTGTTCAGAAGGACATGGCCATCATGATTGAGGATGAAAAGGCTTTAAGGGAAACTGTCCGT AAACTGGGAGTGATTGATTCTGAGAGAATGGACTTTGAGCTGTTGCCCGATGATGAGCGGCAGTGTATAAAGTGCAAAACTACGTGCTTCATGTCTGCCATCTCCTGCTCCTGTAAACCTGGCCTGCT TGTTTGCCTGCATCATGTCAAAGAGCTGTGCTCCTGTCCCCCTTACAAGTATAACCTGCGGTATAGATACACTCTGGATGATCTCTATCCGATGATGAATGCGTTGAAGCTTCGAGCAGAGTCGTACA ATGAATGGGCCTTAAATGTGAATGAAGCCTTGGAAGCAAAGATTAATAAGAAGAAAAGTCTCGTCAGCTTTAAAGCTTTGATTGAAGAATCAGAAATGAAGAAATTCCCAGACAATGATCTTTTGCGT CACCTTCGCCTAGTTACGCAGGATGCAGAAAAGTGTGCCTCTGTTGCCCAGCAGTTGCTTAATGGCAAAAGGCAAACGAGGTATCGATCTGGTGGAGGGAAGTCTCAGAGTCAGCTGACAGTGAATGA GCTTCGGCAGTTCGTGACTCAGCTGTGCGCTCTTCCCTGCGTCCTTAGTCAGACACCACTGCTAAAGGATCTCTTGAATCGTGTGGAAGATTTCCAGCAGCAAAGCCAGAGACTGCTGTCTGAGGAGA GGCCCCGTGCTTCTGAGCTTCAGCAGTTGCTGGATGTCAGCTTCACTTTTGATGTTGAACTTCCACAGCTAGCTGAGATGCGTATCCGCTTAGAACAGGCCCGTTGGCTAGAAGAGGTTCAGCAGGCT TGCCTGGACTCCAGCTCCCTTTCTTTGGATGATATGAGACGACTCATAGACTTAGGGGTGGGGCTAGCTCCATATTCTGCCGTGGAGAAAGCTATGGCCCGCCTGCAGGAACTGCTAACAGTGTCAGA GCACTGGGACGACAAAGCCAAGAGTCTCCTCAGAGCAAGACCTCGGCATTCCTTGAGTAGCCTTGCTACAGCAGTAAAAGAGATGGAGGAGATCCCCGCCTATCTGCCCAATGGTACAGTCCTGAAGG ATTCTGTGCAGAAAGCCAGAGACTGGGTTCAGGATGTAGATGCATTGCAGGCAGGAGGACGCGTGCCAGTGTTAGAAACACTCATTGAACTTGTCGCAAGAGGCCGATCCATCCCGGTACATCTGAAT TCTTTACCCAGATTGGAAATGCTAGTATCCGAGGTTCATGCTTGGAAAGAAAGCGCTGCTAAAACATTCCTGCTTGAGAATTCGCCATACTCTCTGTTAGAGGTTCTTTGTCCTCGGTGTGACATTGG CCTTTTGGGATTGAAAAGGAAGCAGAGAAAGTTGAAGGATCCCTTGCCAAGTGGGAAGAAGAGAAGCACCAAGTTAGAGAGTCTGAGTGATCTGGAAAGGGCTCTGACTGAGAGCAAAGAGACGGCGT CAGCTATGGCAACTCTTGGGGAAGCTCGCCTACGAGAGATGGAAGCTTTGCAGTCTCTCAGATTTGCCAATGAAGAGAAATTGCTGTCACCTGCCCAAGATGTGGAGACGAAGGTTTGCTTGTGTCAG AAGACTCCAGCCACTCCCATGATTCAGTGTGAACTCTGCAGGGATGCTTTCCATACTAGTTGTGTGGCGGTGTCCAGTATTTCACAAAGCTCCCGAATCTGGCTTTGTCCTCACTGTCGAAGGTCAGA GAAGCCTCCATTAGAGAAAATTCTGCCTCTGCTGGCCTCCCTACAGCGTATAAGAGTTCGTCTTCCTGAAGGGGATGCACTCCGATACATGATTGAAAGAACCGTGAACTGGCAACATAGAGCCCAGC AACTGCTTTCTTCAGGGAATCTAAAACTTGTGCAGGACCAAGCGGGTTCTGGACTGTTGTTTAGCAGATGGCCAGCCTCAGCAGGAACGGCGTCAGCAGCAGACAAGGTGTCTCAACCTCCTGGCACA ACATCCTTTTCATTGCCGGAAGACTGGGACAACAGAACCTCATATTTACACTCTCCCTTCTCTACCGGTCAGAGTTGTATCCCCCTTCATGGTTTGAGTCCAGAGGTGAATGAATTGCTGATGGAAGC CCAGTTGCTCCAGGTGTCCCTCCCTGAAGTCCAGGAGCTTTATCAGACTTTACTTACGAAGCCAAGCTCTGCTCAGCAAGCCGACCGAAGCTCACCAGTCAGACCCAGCAGTGAGAAGAACGATTGTC TTCGAGGGAAACGAGATGCAATCAACAGTCTTGAGAGAAAACTGAAAAGACGCCCAGAAAGAGAAGGCCTTCCCAGTGAACGGTGGGATCGAGTTAAAAAAATGCGGACCCCTCAAAAGAAGAAAATC AAACTGAGTCACCCCAAGGACATGAACAATTTCAAATTAGAAAGAGAGCGTAGCTATGACTTAGTCCGGAATGCTGAAACTCATTCCCTGCCCTCAGACACATCCTACTCCGAGCAGGAGGACTCTGA GGATGAAGATGCCATCTGTCCAGCTGTGAGCTGCCTGCAGCCAGAAGGAGATGAGGTGGACTGGGTCCAGTGTGATGGCAGCTGCAATCAGTGGTTTCATCAGGTCTGTGTTGGTGTCTCTCCAGAGA TGGCAGAGAAAGAAGACTACATCTGTGTGCGCTGTACTGGAAAGGACGCACCAAGCCGAAAGTAAAAACAAAACACACACTCACTTCATGTAATTCAGGACTCCAATAAAGAAGATTTCCTCAATCTC AGCAAAGCTACAGGACTGGGATCGAGCCAGCCTGTACACGGTGCTATTTCTATTCCTTATGGGATCATTTTTCCAGAACTCTTTGAAAAAAAGAAAAAACAACTAAAAAATTTTTGACACTTTTTTGT AATTTTTTCCTTAAAAGCTGTTTGTGGTTGTTGAAGTTTAAAATGCTGACTGTTTTTTGCAGGGGTCTCTACTGATTTCGAAGGTCTTGGAGTTTGCACCTTTTTGTGTACAGCATTAACATTGTACT TGTGCCTGGGATACACCGGCCTAAGAGTCTAACTCAGTGTCAGGGCCCAGGACGGGCACCAGAATTCCAGTAGCCCTCGCTGAGCAGCCGCTCTCCTTTCTCTGTCACCACATTGGGGGACTTTTAAG TTTTCACTTTGGGGTTTTTGTTCCTTTCTTTCTCTCCTTTTCCTTTCTGGTAGGCTAGGTTTATTTATCTGAGCAATAACTTCTATGTTGGTTTCAGTGGCTGGAATTAAAACAAAACAAACTTCTAA ACAGTGTGTTGGTTTAGCATTTGGTTAATGTACAGAAAGCAAACGTCTAGTTTCTGGTGTCACTGAACTAGTGATGTAGGAAGAGACTTCGCTGTAAGTAATCGCCACGGCTGTATTTTGGCTTTCTC CCTACTCAGTTCTTCCCCACCCCCATCTCACACCCCACCTTTTTTTTTTTTTTTGGTAGAATGTATCAAATGTTGCAGTTTTTATTGTGGAATAATAAATCCTTGGTCCTCTTATAACACTAGACTAC AGAGCTTCTTCTGCCCTCCCCCCTGTGGGCCTGCACAACCAGAGGGGTTGTTTGCATTTGCTCCTTCCCAGGCAGCCTGCAGCAGGAGTGTGTGTGCTGGAGGAGTCTCTGTAGCCTGATTCTTTGTG GGTCTGGGCCCTCTTGTCCCACTAATAGAGAGTCCCTGTCTTCAAAGACCACAGCCAGTTCTTCAAGCCGTGTTCTTTTTCCATAATCTCTCAGAATGTTGGAGCTGTCCCTCCATCACTCCAGACTG TAAGACAGCACTCCCGTGGAATGCTTGACAGGGAAGTTTGGCCGAGAGTTAAGTTGCTGTGGCCCATCATCTTAGAGGGTTGGTTCTCTTGTATCATTTTTGGAGAACCTTGGGCCTGCCTGGGATTC CTCTGCCTTCTATGTAATTCCATCAGTCTTTCTGGTTGTGGACGGCCCATACCTGTTTGCCCCTGTTCTGTAGAGAGGAGGACTTCCTGGTGAACAGAAGGACAAGCTCTCGCTCACTCGTCTTCCTC ACTGTCTATAGCCATACGCCTGATGGTGGGCAGAGCTAGCAGACCTTTACTAAAACATCAAAAAGCGGTTTGTAAAGTAGCGAGAATTTAAATGTACTGTCCCCTATGCAATCCAGATAATTAAATCT GTTT
hide sequence
RefSeq Acc Id:
XM_063272298 ⟹ XP_063128368
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 48,554,367 - 48,625,721 (+) NCBI
RefSeq Acc Id:
NP_001100647 ⟸ NM_001107177
- UniProtKB:
A6ICC6 (UniProtKB/TrEMBL), A0A0G2K6G9 (UniProtKB/TrEMBL)
- Sequence:
MEPATALPPGPRPALPLGGPGPLGEFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLNFLDQIAKYWELQGSTLKIPHVERKIL DLFQLNKLVAEEGGFAVVCKDRKWTKIATKMGFAPGKAVGSHIRGHYERILNPYNLFLSGDSLRCLQKPNLTSDTKDKEYKPHDIPQRQSVQPSETCPPARRAKRMRAEAMNIKIEPEEATEARTHNL RRRMGCATPKRENEKEVKSTIKQEPTEKKDCVLESEKDKPKSRAKKTATAVDLYVCLLCGSGNDEDRLLLCDGCDDSYHTFCLLPPLHDVPKGDWRCPKCLAQECSKPQEAFGFEQAARDYTLRTFGE MADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKISPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLH WGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKA DVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCIKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYNLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEA KINKKKSLVSFKALIEESEMKKFPDNDLLRHLRLVTQDAEKCASVAQQLLNGKRQTRYRSGGGKSQSQLTVNELRQFVTQLCALPCVLSQTPLLKDLLNRVEDFQQQSQRLLSEERPRASELQQLLDV SFTFDVELPQLAEMRIRLEQARWLEEVQQACLDSSSLSLDDMRRLIDLGVGLAPYSAVEKAMARLQELLTVSEHWDDKAKSLLRARPRHSLSSLATAVKEMEEIPAYLPNGTVLKDSVQKARDWVQDV DALQAGGRVPVLETLIELVARGRSIPVHLNSLPRLEMLVSEVHAWKESAAKTFLLENSPYSLLEVLCPRCDIGLLGLKRKQRKLKDPLPSGKKRSTKLESLSDLERALTESKETASAMATLGEARLRE MEALQSLRFANEEKLLSPAQDVETKVCLCQKTPATPMIQCELCRDAFHTSCVAVSSISQSSRIWLCPHCRRSEKPPLEKILPLLASLQRIRVRLPEGDALRYMIERTVNWQHRAQQLLSSGNLKLVQD QAGSGLLFSRWPASAGTASAADKVSQPPGTTSFSLPEDWDNRTSYLHSPFSTGQSCIPLHGLSPEVNELLMEAQLLQVSLPEVQELYQTLLTKPSSAQQADRSSPVRPSSEKNDCLRGKRDAINSLER KLKRRPEREGLPSERWDRVKKMRTPQKKKIKLSHPKDMNNFKLERERSYDLVRNAETHSLPSDTSYSEQEDSEDEDAICPAVSCLQPEGDEVDWVQCDGSCNQWFHQVCVGVSPEMAEKEDYICVRCT GKDAPSRK
hide sequence
Ensembl Acc Id:
ENSRNOP00000072712 ⟸ ENSRNOT00000087025
Ensembl Acc Id:
ENSRNOP00000073808 ⟸ ENSRNOT00000077928
RefSeq Acc Id:
XP_063128368 ⟸ XM_063272298
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2K6G9 (UniProtKB/TrEMBL), A0A0G2K3N6 (UniProtKB/TrEMBL)
RGD ID: 13698847
Promoter ID: EPDNEW_R9359
Type: initiation region
Name: Kdm5b_1
Description: lysine demethylase 5B
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 13 51,384,449 - 51,384,509 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-17
Kdm5b
lysine demethylase 5B
Kdm5b
lysine (K)-specific demethylase 5B
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2009-05-06
Kdm5b
lysine (K)-specific demethylase 5B
Jarid1b
jumonji, AT rich interactive domain 1B
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-11-06
Jarid1b
jumonji, AT rich interactive domain 1B
Jarid1b
jumonji, AT rich interactive domain 1B (Rbp2 like)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-07
Jarid1b
jumonji, AT rich interactive domain 1B (Rbp2 like)
RGD1565602_predicted
similar to PLU1 (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2006-03-07
RGD1565602_predicted
similar to PLU1 (predicted)
LOC304809
similar to PLU1
Symbol and Name status set to approved
1299863
APPROVED
2006-02-09
LOC304809
similar to PLU1
Symbol and Name status set to provisional
70820
PROVISIONAL